Imaging in support of Cancer Immunotherapy
Portail_admin
| Uncategorised
The pharmaceutical company Roche and the Institute of Pharmacology and Structural Biology (IPBS) share the objective of developing cancer control strategies.
While Roche is a major player in the development of immunotherapy strategies, IPBS aims to identify and characterize new therapeutic targets in the cancer field by using the imaging resources of the TRI- Genotoul platform.